Preventing Disabilities in Children Caused by Leprosy

Preventing Disabilities in Children Caused by Leprosy

January 25, 2018 at 3:19 PM 0 comments

Fiona Graham Communications Officer, Lepra @Lepra_HinA Ashwin Venkatesh Researcher, Polygeia @Polygeia This year, World Leprosy Day falls on Sunday 28th January. The occasion has been observed since 1954 and aims to raise awareness, providing more people with the knowledge to recognise the symptoms, the cure, and to reduce the stigmaRead More

An Interview with Wroclaw Medical University’s Jacek Szepietowski

November 7, 2017 at 12:00 PM 0 comments

Samantha Warne Editor, European Medical Journal This interview took place at the 26th European Academy of Dermatology and Venereology Congress on 16th September 2017. Jacek C. Szepietowski is a member of the Editorial Board of EMJ Dermatology 5.1 and kindly agreed to meet and share his thoughts on the congress.Read More

Interview with Almirall Global Marketing Dermatology Director About New Psoriasis Treatment

November 2, 2017 at 11:10 AM 0 comments

James Coker Senior Editorial Assistant, European Medical Journal @EMJJamesCoker Disclosure: The European Medical Journal has engaged in business transactions with Almirall S.A. Members of the EMJ team were delighted to meet Mr Rajesh Gupta, the Global Marketing Dermatology Director of Almirall, S.A. (Barcelona, Spain), for an exclusive interview onRead More

Leprosy: A Disease That Still Exists

April 26, 2017 at 8:31 AM 0 comments

Fiona Graham Communications Officer, Lepra, Colchester, UK Correspondence to If you think leprosy is a disease of the past, think again. Leprosy is still rife in the developing world and the poorest of communities overseas and is most prevalent in areas in which many live below the poverty lineRead More

Khellin in Vitiligo Treatment

February 13, 2014 at 7:48 PM 0 comments

Dr Agustin Alomar Psoralens + UVA (PUVA) therapy is a well-known treatment for vitiligo, as well as Narrowband-UVB (NB-UVB), but other photochemotherapy regimens for vitiligo consists of khellin as a photosensitiser, a furanochromone extracted of the plant Amni visnaga (5,8 dimetoxi.2 methyl-4,5 furo-6,7 chromone), and UVA irradiation (KUVA). The main advantage isRead More